Cover Image
Market Research Report
Product code 
964972

Vertebroplasty and Kyphoplasty Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Published: | Mordor Intelligence Pvt Ltd | 110 Pages | Delivery time: 2-3 business days

Price

Back to Top
Vertebroplasty and Kyphoplasty Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
Published: January 17, 2022
Mordor Intelligence Pvt Ltd
Content info: 110 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents

The vertebroplasty and kyphoplasty market is expected to register a CAGR of 4.5% over the forecast period, owing to technological advancements in product and increasing burden of vertebral compression fracture. Vertebral compression fractures are the most prevalent fractures in osteoporosis patients.

Key Highlights

  • According to the American Association of Neurological Surgeons, around 75,000 people experience vertebral compression fractures every year. For instance, recently Merit Medical introduced two products for vertebral compression fracture, 'DiamondTOUCH' and 'StabiliT'.
  • The syringe has the capability of injecting cement as well as to inflate and deflate the interventional devices. Hence, these factors are expected to boost the demand for vertebroplasty and kyphoplasty market.
  • However, the clearance of the products related to vertebroplasty and kyphoplasty by regulatory bodies is expected to obstruct the market growth.

Key Market Trends

Kyphoplasty Devices are Expected to Exhibit a Significant Share in the Vertebroplasty and Kyphoplasty Market

Kyphoplasty devices are expected to exhibit significant growth, owing to the changing lifestyle of people. The adaptation of a sedentary lifestyle by the people has led to physical inactivity, which involves high complications and risk. Even in the patients of osteoporosis and osteopenia, physical exercise reduces the risk of vertebral fractures.

Furthermore, the growing prevalence of vertebral compression fracture, and according to the study of Osteoporosis International, in 2017, around 30% - 50% of people worldwide had been affected with a vertebral compression fracture. Also, according to the study of the Journal of Spine Surgery published in 2019, the kyphoplasty that was performed for vertebral height restoration showed significant outcomes. Therefore, these factors are expected to propel the growth of the vertebroplasty and kyphoplasty market in this segment.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global vertebroplasty and kyphoplasty market, owing to the increasing aging population and the presence of product approvals. A vertebral compression fracture is commonly found in the geriatric population. According to the American Association of Neurological Surgeon, a vertebral compression fracture is quite common in older women than men. It affects almost 40% of the women aged 80 and above in the United States. Cardinal Health recently received a US FDA (Food & Drug Administration) approval for its product, 'Ava-Tex Radiopaque Bone Cement', which may be used in the spine fracture surgeries, i.e., vertebroplasty. Such activities may boost the growth of demand and usage for these procedures in the market studied.

Competitive Landscape

The vertebroplasty and kyphoplasty market is fragmented and consists of several major players. In terms of market share, few of the major players have been currently dominating the market. Companies have been taking strategic initiatives to grow their presence in the market studied. For instance, in 2019, Medtronic acquired Titan Spine to expand its product portfolio related to spinal surgery. Some of the companies that are currently dominating the market are Medtronic, Medaid Inc., Teknimed, Cardinal Health, Johnson & Johnson (Depuy Synthes), joimax GmbH, Stryker, Atcomed, Lindare Medical, and Globus Medical.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Product Code: 68641

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Geriatric Population
    • 4.2.2 Technological Advancements in the Products
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Framework
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Vertebroplasty Devices
    • 5.1.2 Kyphoplasty Devices
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 United States
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 United Kingdom
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia-Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle East & Africa
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle East & Africa
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Medtronic
    • 6.1.2 Medaid Inc.
    • 6.1.3 Teknimed
    • 6.1.4 Cardinal health
    • 6.1.5 Johnson & Johnson (Depuy Synthes)
    • 6.1.6 Joimax GmbH
    • 6.1.7 Stryker
    • 6.1.8 Atcomed
    • 6.1.9 Lindare Medical
    • 6.1.10 Globus Medical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS